BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Lung cancer
,
Breast
,
Nosology
,
Ciprofibrate
,
rs2476601
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Liver X receptor
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Livers from rats fed liver X receptor ligand GW3965 and treated with dexamethasone
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
Liver, breast and endometrial cell lines exposed to 34 toxicological compounds
Primary, metastatic and recurring breast cancers with ER, PR, HER2 status and molecular subtypes
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
A structural perspective of liver X receptors.
The versatility of liver X receptors in T cell homeostasis: Location, location, location
Targeting cholesterol homeostasis in hematopoietic malignancies.
Emerging Insights into Liver X Receptor α in the Tumorigenesis and Therapeutics of Human Cancers.
Medicarpin Improves Depressive-Like Behaviors in a Chronic Unpredictable Mild Stress-Induced Mouse M…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD…
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors…
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fa…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ